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Background: Lymphoproliferative disorders causing paraproteinemia can be associated with various kidney injuries
including the deposition of monoclonal immunoglobulins (Ig). A known glomerular manifestation of Waldenström’s
macroglobulinemia is characterized by prominent intracapillary hyaline thrombi and lack of conspicuous glomerular
proliferation. The present case was special in 2 aspects: 1. the diagnosis of glomerulonephritis was unexpected
before renal biopsy, 2. the prominent glomerular proliferation paired with large intracapillary hyaline thrombi is
uncommon in Waldenström’s macroglobulinemia-associated glomerulonephritis.
Case presentation: A 73-year-old Caucasian woman with a long-standing history of rheumatoid arthritis and
Waldenström’s macroglobulinemia was admitted for acute renal failure (ARF), which initially was presumed to be
the consequence of extrarenal causes. Proteinuria and hematuria were only mild. In renal core biopsy, a
membranoproliferative glomerulonephritis (MPGN) and prominent intracapillary hyaline monoclonal IgM thrombi
were found in addition to acute tubular necrosis. Of note, the patient’s history was positive for purpuric skin
changes, suspicious for cryoglobulinemia. However, serological tests for cryoglobulins were repeatedly negative. The
ARF resolved before the start of immunomodulatory therapy for Waldenström’s macroglobulinemia.
Conclusion: The presence of MPGN with prominent hyaline thrombi in the context of Waldenström’s
macroglobulinemia is uncommon and can be oligosymptomatic. We discuss this case in the context of previous
literature and classifications suggested for monoclonal Ig-related renal pathologies.
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Lymphoproliferative malignancies producing monoclonal
immunoglobulins may cause different nephropathies.
Compared to multiple myeloma, renal involvement in
Waldenström’s macroglobulinemia (WM) is much more
seldom and often manifests as IgM deposits along the
glomerular basement membranes, amyloidosis or lym-
phomatous infiltration of the renal parenchyma, whereas
cast nephropathy is almost never observed [1-4]. Morel-
Maroger et al. described a renal manifestation of WM
characterized by prominent intracapillary IgM thrombi
and lack of relevant glomerular proliferation [3]. This
disease pattern has also been referred to as intra-
capillary monoclonal deposits disease (ICMDD) in the
context of any IgM-secreting monoclonal proliferation* Correspondence: Maike.Buettner@uk-erlangen.de
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reproduction in any medium, provided the or[1]. Prominent intracapillary hyaline thrombi can also de-
velop in the context of cryoglobulinemia, containing a
monoclonal immunoglobulin (Ig) often in the context of
lymphoproliferative disorders (type I) or polyclonal with
or without monoclonal Ig (type II and III, respectively),
which may be associated with persistent infections and
autoimmune syndromes [5,6]. Although about 15% of
WM cases are associated with type I cryoglobulins (CG),
few patients have symptoms or complications [2]. Cryo-
globulinemic glomerulonephritis (CG-GN), often reported
in type II cryoglobulinemia, is an exceedingly rare finding
in WM [7].
Case presentation
A 73-year-old Caucasian woman was transferred to the
renal department for acute renal failure (ARF) thought to
be primarily due to extrarenal causes. Her medical history
was notable for rheumatoid arthritis (RA) diagnosed
12 years ago, accompanied by purpuric skin lesions on theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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taken 7 years ago) and arms. Five months ago, one lesion
developed into a pretibial ulcer on her right leg, for which
she underwent skin grafting. 5 years ago, serum protein
studies revealed a monoclonal IgM gammopathy. A bone
marrow biopsy performed 4 months ago because of wor-
sening anemia yielded the diagnosis of lymphoplasmacytic
lymphoma. Her recent medical history was marked by
progressive dyspnea due to pleural effusions. Before trans-
fer to our hospital, the serum creatinine was 2.4 mg/dl, as
compared to 1.07 mg/dl five months ago.
At physical examination, the patient’s temperature
was 38.2°C and her blood pressure was 110/70 mmHg.
At the lung bases, the chest was dull to percussion with
diminished breath sounds. The cardiac and abdominal
examinations were normal. The extremities were re-
markable for pitting ankle edema. The hands showed
ulnar deviation and swan neck deformity. The skin
revealed an unremarkable skin grafting wound on her
right, and discrete palpable purpura on her left pretibial
region. Renal ultrasound was normal. Although cardiac
decompensation was suspected because of dyspnea,
edema and pleural effusions and an elevation of BNP
(2108 pg/ml), echocardiography showed only a slightly
decreased cardiac ejection fraction (40-50%).
Laboratory data included a serum creatinine of
2.54 mg/dl and BUN of 96 mg/dl. Urine dipstick evalu-
ation showed 2+ blood and no protein. The urinary
sediment contained 292 erythrocytes/μl without dys-
morphic forms. Additional laboratory tests performed
during hospitalization included: high levels of rheuma-
toid factor (881 IU/ml) and anti-CCP antibodies (>340Figure 1 Purpuric skin changes of the lower legs. Photograph
taken 7 years prior to admission and five years after the initial
diagnosis of RA showing purpura of the legs.U/ml), normal ANA serology, and negative hepatitis C
serology. Urinary protein excretion was 1.23 g/24 h,
Bence-Jones lambda was 226 mg/dl and Bence-Jones
kappa 77.2 mg/dl. The serum protein electrophoresis
showed a monoclonal IgM lambda band; serum IgM was
31.4 g/l. Despite repeated testing, CG serology remained
negative.
A renal biopsy was performed.
Light microscopy showed renal parenchyma with 31
glomeruli (one obliterated), which were hypercellular with
prominent mesangial and intracapillary proliferation,
prominent intracapillary PAS-positive thrombi in most
glomeruli and double contoured basement membranes
(Figure 2A and B). Extracapillary proliferation was absent.
In immunohistochemical stainings, the thrombi were
strongly reactive for IgM and lambda light chains without
reactivity for kappa light chains, IgA, IgG, C1q and C3c. A
granular peripheral positivity of the glomerular capillaries
was seen in IgM, IgG and C3c as well as in the lambda
and to a lesser extent kappa light chain stainings. CD68
staining showed a dense histiocytic infiltration of the
glomeruli (Figure 2C-F). Congo red staining was negative.
Signs of acute tubular necrosis were present.
In electron microscopy (EM) a prominent increase in
mesangial matrix and mesangial and intracapillary hyper-
cellularity with numerous inflammatory cells were seen
(Figure 2G and H). The glomerular basement membranes
focally showed mesangial cell interposition. Podocytes
presented with foot-process effacement. The most strik-
ing finding was intracapillary deposits of electron-dense
granular material, which, even at very high magnification,
showed no fingerprint or tubuloreticular structures.
Electron-dense deposits with identical structure were
found subendothelially and intramembranously.
The lesion was classified as membranoproliferative
glomerulonephritis (MPGN) with intracapillary IgM
deposits in the context of WM accompanied by acute
tubular necrosis. Because of the pattern of glomerulo-
nephritis with an MPGN-like picture and prominent
hyaline thrombi, an association with cryoglobulinemia
was suggested.
In the further clinical course the ARF subsided with-
out specific treatment and creatinine levels declined
from 3.04 mg/dl to 1.3 mg/dl three weeks after admis-
sion. Nevertheless, we initiated an immunomodulatory
therapy with rituximab, after which renal function con-
tinued to fluctuate. Repeated CG testing remained
negative.
Conclusions
The reported case of MPGN with intracapillary thrombi
is remarkable in several aspects.
First, because of heart failure signs and highly elevated





Figure 2 Light microscopy, immunohistochemistry and electron microscopy of MPGN with intracapillary IgM thrombi with lambda
light-chain restriction. (A) Periodic-acid Schiff (PAS) staining (400x) with numerous intracapillary PAS positive thrombi and prominent
intracapillary and mesangial proliferation, (B) Silver staining with double contoured basement membranes as highlighted in the inlay (400x), (C)
IgM immunohistochemistry with strong staining of the thrombi and basement membranes (400x). (D) CD68 immunohistochemistry showing
dense mesangial and intracapillary infiltration of the glomeruli by monocytes/macrophages (400x). (E) lambda (400x) and (F) kappa (400x) light-
chain immunohistochemistry with a lambda light-chain restriction in the thrombi. Inlays show thrombi (630x). (G) Electron microscopy showing a
basement membrane with segmental cellular interposition and subendothelial and intramembranous electron-dense deposits as well as an
intracapillary thrombus (3597x). (H) The electron-dense deposits show a granular structure. No tubulo-reticular structures are present (21560x,
inlay 60000x). Magnifications are indicated as original magnifications.
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abnormal echocardiographic findings could be explained
by the fact that at the time of the examination, cardiac
function was already recovering from an acute event.
The urine analysis showed only mild proteinuria and
hematuria without dysmorphic erythrocytes, so that no
distinct glomerular disease was expected. However, renal
biopsy, in addition to the expected acute tubular necro-
sis, revealed a proliferative glomerulonephritis necessi-
tating a specific immunomodulatory therapy. The renal
function recovered before the start of the therapy, again
arguing for a prerenal cause of acute renal failure. Thus,
the finding of the glomerulonephritis was ‘incidental’ in
the context of a renal biopsy performed for acute renal
failure. Moreover, proliferative GN reported in the con-
text of monoclonal lymphoproliferations is often asso-
ciated with nephrotic syndrome [1,8,9], which was not
true for our case, so that the MPGN pattern of injury
was even less expected. Secondly, from the morpho-
logical point of view our case was reminiscent of CG-
GN with monoclonal type I CG [10,11], which would go
very well in line with the glomerular proliferation and
the purpuric skin manifestation. While a microtubular
or fingerprint ultrastructure on EM is very specific for
CG-GN, a finding of granular deposits as seen in our
case does not prove or exclude this disorder [10,12].
Nevertheless, CG-GN could not be proven because of
repeatedly negative CG testing.
Another entity that might be considered in the differ-
ential diagnosis is WM-associated nephropathy with
prominent intracapillary thrombi and, contrary to our
case, lack of relevant proliferation or histiocytic infiltra-
tion [1,3].
In monoclonal deposit nephropathies, CG presence
very often is seen tied to the feature of cellular prolifera-
tion [10]. However, several reports in literature can be
found describing monoclonal intrarenal IgM deposits
and marked glomerular proliferation sometimes with the
typical picture of MPGN without proof of CG [1,4,8,13-15].
Interestingly, negativity for CG is also present in a
recently described proliferative glomerulonephritis with
monoclonal IgG deposits (PGNMID) [16]. Comparable
to this entity associated with IgG, recently a case of pro-
liferative GN with monoclonal IgM deposits, but without
association with WM, was reported [9]. This showed
several similarities with the present case, including lack
of evidence of CG, presence of a monoclonal IgM and
prominent proliferation [9], so that this case and ours
might both be classified as proliferative GN with mono-
clonal IgM deposits. In contrast to other reported cases
that might belong to this group [9] our patient showed a
lambda light chain restriction and was female, so that
apparently this pattern of injury is not restricted to men
and kappa light chain producing lymphoproliferation.The concomitantly observed minor peripheral capillary
deposits of IgG, kappa light chains and C3c might
either represent a trapping of immunoglobulins and
complement in the widened basement membranes or
be due to an immune activation maybe caused by the
monoclonal IgM.
Presence of CG, conversely, is not always accompanied
by prominent glomerular proliferation [3,17]. Thus, glo-
merulopathies associated with monoclonal gammopathies
include a spectrum of proliferative and non-proliferative
GN which can, but need not be associated with the pres-
ence of CG. In addition, RA and its treatments can also
lead to MPGN [18]. Therefore it cannot be excluded that
in the present case RA might be involved in the pathogen-
esis of MPGN.
Treatment for WM is usually indicated for conditions
like progressive, severe anemia and hyperviscosity syn-
drome [19], for which there was no evidence in the
present patient. Given the impressive renal changes
linked to deposition of monoclonal antibodies, we
nevertheless felt the urge to treat and suppress their
production. The optimal treatment regimen for intrare-
nal monoclonal deposit disorders has yet to be defined.
In general, treatment of the malignancy is expected to
alleviate glomerulopathy [13]. Because of the patient’s
poor general condition, we opted for monotherapy with
rituximab. This case illustrates the need for renal bi-
opsy in ARF patients with a positive history for diseases
that may be associated with more unusual forms of
nephropathy.
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